Longevity Acceleration Podcast

In this 1.5-hour episode of the podcast, we dive deep into the cutting-edge world of longevity research with Peter Fedichev, founder of Gero, and Aleksandr Sviridov. The conversation explores the intersection of physics, biology, and aging, offering fascinating insights into the current state and future potential of longevity science. Key topics discussed include: The application of physics tools to understand aging and the importance of a phenomenological approach Distinguishing between reversible and irreversible aspects of aging Challenges in biological data collection and the shift towards more quantitative approaches The potential of large public datasets and plasma proteomics in drug discovery Establishing a standard model of aging and identifying variables related to maximum human lifespan The limitations of lifespan as a measure of aging and the need for more comprehensive variables Potential interventions including pharmacological, cellular, and gene therapies Alternative approaches such as organ replacement and cryostasis The concept of epigenetic rejuvenation and its challenges Peter and Aleksandr discuss the need for exceptional talent, funding, and collaboration across fields to accelerate progress in longevity research. They emphasize the importance of prevention alongside repair in addressing aging-related damage. The episode provides listeners with a comprehensive overview of the current state of longevity science, highlighting both the challenges and the promising avenues for future research. It underscores the need for a multidisciplinary approach, combining insights from physics, biology, and data science to unlock the secrets of aging and potentially extend human healthspan. For those interested in diving deeper into the field, the speakers recommend following experts like Matt Kaeberlein and Peter Attia for additional insights. This episode offers a thought-provoking exploration of longevity science, suitable for both experts in the field and curious listeners looking to understand the frontier of aging research.

Jean Hebert is a professor of genetics and neuroscience at the Albert Einstein College of Medicine. In this interview, he discusses his strategy of replacing ageing as a pathway to longevity, shifting focus from genetics to brain tissue replacement due to ageing complexities. He emphasizes the potential of gene delivery technology and brain replacement for longevity. The conversation covers tissue replacement, particularly cortical tissue, and other brain structures like the hypothalamus. Jean addresses surgery challenges, the need for improved techniques, and estimated costs of $3 to $10 billion. We also discuss reversible cryostasis, advancements in cryopreservation, and the ethical implications of brain replacement and destructive uploading, alongside strategies to attract talent and funding to the longevity field.

Is there a plan to cure aging? No concrete plan exists on the websites of the National Institute on Aging or any longevity biotech company website. But we need a plan. Solving aging is one of the most challenging and meaningful technological achievements humanity will ever undertake. Mark Hamalainen and Nathan Cheng, the co-directors of the Longevity Biotech Fellowship, introduce an outline for a technical roadmap to solve aging and the accompanying podcast series.